HRT Financial’s Apyx Medical APYX Stock Holding History

HRT Financial’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-24,214	Closed	-$335K	–	3138
2021 Q3	$335K	Sell	24,214 -8,418	-26%	-$88.5K	﹤0.01%	2335
2021 Q2	$336K	Buy	+32,632	New	+$323K	﹤0.01%	2076

Other funds holding APYX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return

HRT Financial's APYX Position: Q4 2021 in Review

HRT Financial sold out of Apyx Medical (APYX) in Q4 2021, closing a stake of 24,214 shares — an estimated $335K sold.

HRT Financial first reported a position in APYX in Q2 2021 and held it in 2 quarters. The position peaked at $336K in Q2 2021. 75 funds tracked by Wall St. Rank hold APYX as of Q4 2021.

HRT Financial reported no remaining Apyx Medical position as of Q4 2021 after selling out during the quarter.
HRT Financial sold 24,214 Apyx Medical shares in Q4 2021, an estimated $335K.
HRT Financial first reported a position in Apyx Medical in Q2 2021 and held it in 2 quarters.
HRT Financial's Apyx Medical position peaked at $336K in Q2 2021.
75 funds tracked by Wall St. Rank held Apyx Medical as of Q4 2021.

Based on HRT Financial's 13F filing for Q4 2021, filed 14 Feb 2022.